Larimar Therapeutics, Inc. Common Stock (LRMR) is a publicly traded Healthcare sector company. As of November 4, 2026, LRMR trades at $2.74 with a market cap of $263.86M and a P/E ratio of 0.00. LRMR moved +8.86% today. Year to date, LRMR is -17.53%; over the trailing twelve months it is -27.08%. Its 52-week range spans $1.61 to $6.42. Analyst consensus is strong buy with an average price target of $16.33. Rallies surfaces LRMR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest LRMR news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $2.74 |
| Market Cap | $263.86M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.42 |
| 52-Week Low | $1.61 |
| Volume | 1.92M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-165.67M |
| Gross Margin | 0.00% |
4 analysts cover LRMR: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $16.33.